Target Name: IL16
NCBI ID: G3603
Other Name(s): Pro-interleukin-16 (isoform 3) | prIL-16 | PrIL-16 | Neuronal interleukin 16 | FLJ16806 | NIL16 | Interleukin 16, transcript variant 3 | Pro-interleukin-16 (isoform 1) | FLJ42735 | Interleukin 16, transcript variant X1 | Prointerleukin 16 | interleukin 16 | IL16 variant 3 | Interleukin 16, transcript variant 1 | Interleukin-16 | PRIL16 | IL16 variant 1 | lymphocyte chemoattractant factor | LCF | Pro-interleukin-16 | IL16_HUMAN | Lymphocyte chemoattractant factor | prointerleukin 16 | Interleukin-16 (IL-16) | Pro-interleukin-16 (isoform X1) | IL16 variant X1 | IL-16 | neuronal interleukin 16

IL16: A Key Protein in The Immune System

IL16 (Pro-interleukin-16 (isoform 3)) is a protein that is expressed in a variety of tissues throughout the body. It is a key player in the immune system, as it helps to regulate the activity of natural killer cells. In recent years, researchers have become increasingly interested in IL16 as a potential drug target or biomarker, due to its unique biology and the potential benefits it could bring to treating various diseases.

IL16 was first identified in the 1970s as a key regulator of the immune response. It is a glycoprotein that is composed of four subunits: alpha, beta, gamma, and delta. IL16 is typically produced in the cytosol of macrophages, and it has been shown to play a critical role in the regulation of natural killer cells (NK cells), which are a key part of the immune system.

NK cells are a type of white blood cell that play a critical role in fighting off infections and cancer. They are able to recognize and destroy infected or abnormal cells, without the need for any immunological response from the rest of the immune system. IL16 is one of the key proteins that helps to regulate the activity of NK cells.

One of the key functions of IL16 is its ability to stimulate the production of NK cells. NK cells are a critical part of the immune system, and they are able to detect and destroy infected or abnormal cells in the body. IL16 has been shown to stimulate the production of NK cells by promoting the production of cytokines, which are a type of signaling molecule that help to coordinate the immune response.

IL16 is also involved in the regulation of the apoptosis, which is the process by which cells die naturally in the body. Apoptosis is an important part of the immune response, as it helps to remove damaged or infected cells from the body. IL16 has been shown to play a critical role in regulating apoptosis in NK cells, by promoting the production of pro-apoptotic proteins.

In addition to its role in regulating the immune response, IL16 has also been shown to have a variety of other functions. For example, it has been shown to play a critical role in the regulation of inflammation, by promoting the production of pro-inflammatory cytokines. IL16 has also been shown to play a critical role in the regulation of cell proliferation, by promoting the production of growth factors.

Despite its importance in the immune system, IL16 is not yet widely understood. There is currently a lack of effective therapies that can specifically target IL16, which makes it difficult to study its potential benefits. However, researchers are slowly beginning to gain a better understanding of IL16's biology and its potential as a drug target or biomarker.

One of the most promising areas of research into IL16 is its potential as a therapeutic target. IL16 has been shown to play a critical role in the regulation of the immune response, and it is possible that it could be used to treat a variety of diseases. For example, IL16 has been shown to be involved in the development of cancer, and it is possible that it could be used to treat cancer by inhibiting its activity.

In addition to its potential as a therapeutic target, IL16 is also being studied as a potential biomarker. IL16 has been shown to be expressed in a variety of tissues throughout the body, and it is possible that it could be used as a marker for certain diseases. For example, IL16 has been shown to be elevated in the blood of people with multiple sclerosis, a

Protein Name: Interleukin 16

Functions: Interleukin-16 stimulates a migratory response in CD4+ lymphocytes, monocytes, and eosinophils. Primes CD4+ T-cells for IL-2 and IL-15 responsiveness. Also induces T-lymphocyte expression of interleukin 2 receptor. Ligand for CD4

More Common Targets

IL17A | IL17B | IL17C | IL17D | IL17F | IL17RA | IL17RB | IL17RC | IL17RD | IL17RE | IL17REL | IL18 | IL18BP | IL18R1 | IL18RAP | IL19 | IL1A | IL1B | IL1F10 | IL1R1 | IL1R2 | IL1RAP | IL1RAPL1 | IL1RAPL2 | IL1RL1 | IL1RL2 | IL1RN | IL2 | IL20 | IL20RA | IL20RB | IL21 | IL21-AS1 | IL21R | IL21R-AS1 | IL22 | IL22RA1 | IL22RA2 | IL23A | IL23R | IL24 | IL25 | IL26 | IL27 | IL27RA | IL2RA | IL2RB | IL2RG | IL3 | IL31 | IL31RA | IL32 | IL33 | IL34 | IL36A | IL36B | IL36G | IL36RN | IL37 | IL3RA | IL4 | IL4I1 | IL4R | IL5 | IL5RA | IL6 | IL6-AS1 | IL6R | IL6R-AS1 | IL6ST | IL6ST-DT | IL6STP1 | IL7 | IL7R | IL9 | IL9R | IL9RP3 | IL9RP4 | ILDR1 | ILDR2 | ILF2 | ILF3 | ILF3-DT | ILK | ILKAP | ILRUN | ILVBL | Imidazoline I2 receptor (I2) | Imidazoline I3 receptor (I3) | Imidazoline receptor | IMMP1L | IMMP2L | IMMT | IMMTP1 | Immunoglobulin A | Immunoglobulin E (IgE) | Immunoglobulin G | Immunoglobulin M | Immunoglobulin-Like Domain Containing Receptor | Immunoproteasome